News
Speedy delivery of COVID-19 vaccine a huge challenge globally: WHO experts
As India launches the world’s most ambitious and biggest vaccination drive against COVID-19, the country will encounter the formidable challenge of rapidly scaling up distribution of the vaccines to secure immunity for its entire population, said Dr Soumya Swaminathan,...
News
Pharma-manufacturing network likely to remain unscathed despite COVID-19
Most of the pharmaceutical companies do not plan to change their manufacturing network despite the possibility that COVID-19 pandemic may disrupt supply channels.
GlobalData has conducted a survey to assess how the finished dose product supply network and small molecule...
News
Akston Biosciences and LakePharma Enter Covid-19 Partnership
Akston Biosciences, which develops new classes of biologic therapeutics, and LakePharma, a U.S.-based CRDMO serving the biotechnology community with development and production services, have established a strategic partnership.
LakePharma will manufacture commercial quantities of Akston’s adjuvated COVID-19 vaccine candidate (AKS-452),...
Drug Research
INOVIO, Advaccine Enter Exclusive COVID-19 DNA Vax Pact
INOVIO, a biotechnology company focused on precisely designed DNA medicines to treat and prevent infectious diseases and cancer, and Advaccine Biopharmaceuticals Suzhou, an emerging biotech company with next-gen technology in vaccines, have entered into a collaboration and license agreement...
Clinical Trials
Bharat Biotech vaccine approved in clinical trial mode, consent of participants has to be taken: ICMR
Balram Bhargava, chief of Indian Council of Medical Research (ICMR), said on Tuesday that Bharat Biotech’s Covid-19 vaccine has been cleared in the clinical trial mode, which means consent of participants has to be taken. He was responding to...
News
Chemo Drug Potentially More Potent than Remdesivir Against Coronavirus
Researchers with Shenzhen Institutes of Advanced Technology in China used a variety of computational techniques to simulate drug-virus interactions. They then screened 1,906 existing drugs to evaluate which ones might inhibit replication of SARS-CoV-2, the virus that causes COVID-19.
From...
News
Covid 19: An opportunity in disguise for E-Pharmacies in India
Apex industry body, Federation of Indian Chambers of Commerce & Industry (FICCI) has forecasted that the e-pharmacies in India will grow rapidly and cater to an approximate 70 million households in India within the next four years (by FY2025)....
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
















